Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system

The olfactory bulbectomy model in mice and rat: One story or two tails?

(2015) Hendrikus Hendriksen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The Mysterious Motivational Functions of Mesolimbic Dopamine

(2012) John D. Salamone et al.   NEURON

Influence of olfactory bulbectomy on maternal behavior and dopaminergic function in nucleus accumbens in mice

(2010) Atsushi Sato et al.   BEHAVIOURAL BRAIN RESEARCH

Effect of non-selective dopaminergic receptor agonist on disrupted maternal behavior in olfactory bulbectomized mice

(2010) Atsushi Sato et al.   BEHAVIOURAL BRAIN RESEARCH

Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia

(2009) Angèle Consoli et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats

(2009) Megan E. Breuer et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

WS-50030 [7- -1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D2 Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity

(2009) J. A. Brennan et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD

(2009) Xueliang Fan et al.   NEUROBIOLOGY OF DISEASE

SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model

(2008) M. E. Breuer et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY